Extracorporeal Shock-Wave Therapy for Elbow Osteochondritis Dissecans
Phase 1
Recruiting
- Conditions
- Elbow Osteochondritis DissecansOsteochondritis Dissecans
- Registration Number
- JPRN-jRCTs062190010
- Lead Sponsor
- Matsuura Tetsuya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
Elbow Osteochondritis Dissecans
Exclusion Criteria
Patients with losse bodies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Repair of lesion
- Secondary Outcome Measures
Name Time Method pain, range of motion, tenderness, pain at stress test<br>pain and/or erythema at ESWT<br>growth disorder
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the effectiveness of extracorporeal shock-wave therapy in elbow osteochondritis dissecans?
How does extracorporeal shock-wave therapy compare to arthroscopic surgery for treating osteochondritis dissecans in pediatric patients?
Are there specific biomarkers that predict response to shock-wave therapy in elbow osteochondritis dissecans cases?
What are the potential adverse events associated with extracorporeal shock-wave therapy in phase I trials for osteochondritis dissecans?
What combination therapies are being explored alongside shock-wave treatment for elbow osteochondritis dissecans in clinical research?